However, McSherry and colleagues reported that the expression of JAM-A is positively correlated with poor prognosis in invasive breast cancer patients, indicating that JAM-A promotes cell motility in breast cancer by activating Rap 1 GTPase (McSherry et al., 2011). Here, F11R is linked to breast carcinoma.